Gland Pharma Limited
MainboardlistedGLANDINE068V01023- DRHP filed10 Jul 20
- RHP filednot stated yet
- Open09 Nov 20
- Close11 Nov 20
- Listed20 Nov 20
Issue
- Price band
- ₹1490–1500
- Issue price
- ₹1500
- Face value
- ₹1
- Lot size
- 10
- Issue size
- ₹6,479.55 Cr
- Fresh / OFS
- ₹1,250 Cr / ₹5,229.55 Cr
- Issue type
- book built
- Registrar
- Link Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- +21.3%
- 1 month
- +54.6%
- 3 months
- +59.3%
- 6 months
- +110.6%
- 1 year
- +136.0%
- Current (03 Nov 26)
- +110.6%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY18 | 1,622.9 | 321.1 | 2,929.5 | |||
| FY19 | 2,044.2 | 451.9 | 3,523.5 | |||
| 30 Jun 19 | 674.5 | 183.8 | 3,688.5 | |||
| FY20 | 2,633.2 | 772.9 | 4,086 | |||
| 30 Jun 20 | 884.2 | 313.6 | 4,691.3 |
Reservation · share of the issue the offer document allocates to each category
- qib
- 50%
- nii
- 15%
- retail
- 35%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| nii | combined | 0.51× |
| qib | combined | 6.40× |
| retail | combined | 0.24× |
| total | combined | 2.06× |
Lead managers
Citigroup Global Markets India Private Limited · Haitong Securities India Private Limited · Kotak Mahindra Capital Company Limited · Nomura Financial Advisory and Securities (India) Private Limited